NCT00107003View on ClinicalTrials.gov

GW572016 to Treat Recurrent Malignant Brain Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 30, 2005

Primary Completion Date

December 5, 2007

Study Completion Date

November 30, 2012

Conditions
GliomaBrain TumorGlioblastoma MultiformeGBMGliosarcomaGS
Interventions
DRUG

lapatinib ditosylate

PROCEDURE

Adjuvant therapy

PROCEDURE

Conventional surgery

PROCEDURE

Neoadjuvant therapy

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00107003 - GW572016 to Treat Recurrent Malignant Brain Tumors | Biotech Hunter | Biotech Hunter